Key result
Cx40 and KCNA5 mRNA and protein expression were significantly downregulated in the atrial myocytes of patients with atrial fibrillation compared to those with rheumatic heart disease.
Case-Control (n=60)
No
p-value: p=<0.01
Cx40 and KCNA5 are downregulated in AF and synergistically regulate each other, suggesting combined electrical and structural remodeling in AF pathogenesis.
Structural and electrical remodeling within the atrium mediate the pathogenesis of atrial fibrillation (AF). Two key genes that sever a role in this remodeling are connexin 40 (Cx40) and potassium voltage-gated channel subfamily A member 5 (KCNA5), respectively. Electrical remodeling is considered to induce structural remodeling during AF. In the present study, the left atrial appendage section and atrial myocytes of patients with AF were evaluated. It was observed that Cx40 and KCNA5 mRNA (P<0.05) and protein (P<0.01) expression was significantly downregulated in AF compared with rheumatic heart disease. In addition, a positive correlation between the mRNA expression Cx40 and KCNA5 was observed in the atrial myocytes of patients with AF (P<0.05; r=0.42). The association between Cx40 and KCNA5 expression was subsequently investigated in primary cultured atrial myocytes using siRNA transfection. In atrial myocytes, downregulation of Cx40 inhibited the expression of KCNA5. Similarly, silencing of KCNA5 suppressed the expression of Cx40. These results indicate that synergistic regulation may occur between Cx40 and KCNA5 expression. Furthermore, the combined effects of electrical and structural remodeling in the atrial myocytes of patients with AF may contribute to the pathogenesis of AF.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2017) conducted a case-control in Atrial Fibrillation (n=60). Atrial fibrillation (disease state) vs. Rheumatic heart disease was evaluated on Cx40 and KCNA5 mRNA and protein expression (p=<0.01). Cx40 and KCNA5 mRNA and protein expression were significantly downregulated in the atrial myocytes of patients with atrial fibrillation compared to those with rheumatic heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: